News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter

Pharmacokinetics Leader ClinPharm Consulting Exhibiting at ACCP Annual Meeting

9/20/2012 1:37:39 PM

(Research Triangle Park, N.C.) The pharmaceutical industry's go-to resource for pharmacokinetics (PK), ClinPharm Consulting, LLC, will be hosting a booth at the Annual Meeting of the American College of Clinical Pharmacology (ACCP) September 23-25, 2012 in San Diego, California to share PK expertise and showcase the firm's selection of focused, collaborative services.

The ACCP Annual Meeting is a highly anticipated event for national and international healthcare professionals and leaders in the fields of clinical pharmacology, drug development, and the optimal use of therapeutic products as they relate to ensuring drug effectiveness and safety.

"We are excited to once again learn and present information on important, cutting-edge clinical pharmacology and PK developments while connecting with drug developers and scientific leaders from across the United States and overseas," said ClinPharm CEO Geoff Banks, Ph.D.

Titled "Translating Clinical Pharmacology Research into Optimized Patient Care," this year's ACCP Annual meeting will feature workshops and symposia on innovations in drug therapies, clinical translational biomarkers, pediatric drug development, chronic pain, asthma and psychotropics; the role of clinical pharmacology in speeding the development of new anti-infective drugs to combat drug resistance; and pharmacometrics in hospital-based pharmacotherapy, in addition to many others.

According to Dr. Banks, networking with peers and sharing best practices while exhibiting at the ACCP Annual Meeting matches with ClinPharm's ongoing efforts to make clinical pharmacology and pharmacokinetics more accessible and understandable for the pharmaceutical industry. The firm recently launched a revamped web presence,, featuring informative videos, white papers, and other educational materials on clinical pharmacology and drug development issues; participated in the inaugural Triangle Research Symposium in Research Triangle Park, N.C. with a presentation on biosimilars by Dr. Banks; and expanded its team of leading clinical pharmacology and PK professionals with David Y. Mitchell, Ph.D., who is deeply engaged in the greater pharma community in his role as President of the American Association of Pharmaceutical Scientists (AAPS).

"As the global pharmaceutical industry looks to greater collaboration and outsourcing of research, ClinPharm is uniquely positioned to give clients access to a winning combination of experienced, expert PK and clinical pharmacology consultants across a multitude of therapeutic areas, all within the context of a well-established consulting firm," Dr. Banks explained.

ClinPharm continues to engage in events such as ACCP, providing access to its senior team of Ph.D.s in pharmacokinetics, pharmacology, protein biochemistry, molecular biology and others, with experience in a large range of therapeutic areas including orphan drugs and rare diseases.

In October, ClinPharm will be participating in the AAPS Annual Meeting and Exhibition in Chicago, Illinois.

For more information on ClinPharm's integrated, flexible PK and clinical pharmacology outsourcing options visit

About ClinPharm Consulting

ClinPharm Consulting, LLC is a clinical pharmacology consulting firm specializing in pharmacokinetics (PK). Fast becoming the pharmaceutical industry's go-to resource for PK, ClinPharm gives pharmaceutical companies and CROs rare access to a hands-on team of leading clinical pharmacology and PK professionals experienced in a multitude of therapeutic areas. We embrace the notion that simplicity and clarity lead to good decisions by taking complex PK principals and making them understandable and usable for common sense drug development. ClinPharm's flexible business structure enables us to integrate with our clients and help them maximize the potential of clinical pharmacology studies and PK analyses to pave the way toward marketing approval. For more information visit

Read at

comments powered by Disqus